Document is current
Any future updates will be listed below
-
Authors
Di Mario, Carlo
Genovese, Stefano
Lanza, Gaetano A.
Mannucci, Edoardo
Marenzi, Giancarlo
Sciatti, Edoardo
Pitocco, Dario
,
Avogaro, Angelo
Bertuzzi, Federico
Bonora, Enzo
Borghi, Claudio
Buzzetti, Raffaella
Carugo, Stefano
Capodanno, Davide
Consoli, Agostino
Conti, Antonio
Danesi, Rossella
Bartolo, Paolo
Ferrari, Gaetano Maria De
Favale, Stefano
Giorda, Carlo
Giorgino, Francesco
Girelli, Angela
Golino, Paolo
Grigioni, Francesco
Indolfi, Ciro
Irace, Concetta
Lovati, Elisabetta
Maffettone, Ada
Masulli, Maria
Oliva, Fabrizio G
Oltrona Visconti, Luigi
Orsi, Emanuela
Pagotto, Uberto
Paloscia, Leonardo
Parati, Gianfranco
Perrone, Pasquale
Piccirillo, Gianfranco
Pozzilli, Paolo
Pugliese, Giuseppe
Purrello, Francesco
Ribichini, Flavio
Rubboli, Andrea
Senni, Michele
Trevisan, Roberto
Tubili, Claudio
Uguccioni, Massimo
-
Funding
Funding for this research was provided by:
Abbott Diabetes Care
- License Information
-
More Information
Article History
Received: 13 March 2022
Accepted: 14 July 2022
First Online: 27 August 2022
Declarations
:
: The study is based on a survey that does not involve the participation of human subjects nor patient data management and does not aim to modify the current clinical practice of participants. Consequently, this study did not require ethical approval.
: Not applicable.
: all authors report personal fees from Abbott Diabetes Care, during the conduct of the study. S.G. reports personal fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Hikma Pharmaceuticals, Merck Sharp & Dhome, Molteni Farmaceutici, Novartis, Novo Nordisk, Sanofi, Takeda, Teva, Zentiva, outside the submitted work.
